(Q36297833)

English

Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

Pim van der Harst

4

object named as

Pim van der Harst

0 references

Dirk J van Veldhuisen

9

object named as

Dirk J van Veldhuisen

1 reference

Europe PubMed Central

13 August 2017

author name string

Chris P H Lexis

1

1 reference

Europe PubMed Central

13 August 2017

Iwan C C van der Horst

2

1 reference

Europe PubMed Central

13 August 2017

Erik Lipsic

3

1 reference

Europe PubMed Central

13 August 2017

Pim van der Harst

4

1 reference

Europe PubMed Central

13 August 2017

Anouk N A van der Horst-Schrivers

5

1 reference

Europe PubMed Central

13 August 2017

Bruce H R Wolffenbuttel

6

1 reference

Europe PubMed Central

13 August 2017

Rudolf A de Boer

7

1 reference

Europe PubMed Central

13 August 2017

Albert C van Rossum

8

1 reference

Europe PubMed Central

13 August 2017

Bart J G L de Smet

10

1 reference

Europe PubMed Central

13 August 2017

GIPS-III Investigators

11

1 reference

Europe PubMed Central

13 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2012

1 reference

Europe PubMed Central

13 August 2017

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

13 August 2017

26

1 reference

Europe PubMed Central

13 August 2017

5

1 reference

Europe PubMed Central

13 August 2017

417-426

1 reference

Europe PubMed Central

13 August 2017

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Targeting myocardial substrate metabolism in heart failure: potential for new therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

The cardioprotective effects of metformin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

AMP-activated protein kinase: also regulated by ADP?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Standards of medical care in diabetes--2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin use and mortality among patients with diabetes and atherothrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin activates AMP kinase through inhibition of AMP deaminase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin use and mortality in ambulatory patients with diabetes and heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin: taking away the candy for cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Neurohormonal profile of patients with heart failure and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Metformin: An Update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Infarct scar: a dynamic tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

30 September 2017

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

29 June 2018

Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

29 June 2018

Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6413-1

21 January 2018

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464381

5 December 2018

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22968678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Secondary prevention following myocardial infarction may be improved. Long-term medication use according to practice guidelines]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22968678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/22968678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of routine admission laboratory tests to predict thirty-day mortality in patients with acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22968678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10557-012-6413-1

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36297833&oldid=1632224971"